In describing chronic liver disease on imaging, which elements should be included?

In describing chronic liver disease on imaging, which elements should be included?

• A. Only contour
• B. Nodularity, contour, spleen size, portal hypertension signs, and correlate with clinical and labs for diagnosis
• C. Correlate with labs only
• D. Only portal vein thrombosis

Answer: (B)

Describing chronic liver disease on imaging relies on a complete picture of liver morphology and the downstream effects of portal hypertension, all interpreted in the clinical and laboratory context. The nodular, irregular liver surface and altered parenchymal texture point to cirrhosis, while the size of the spleen helps gauge portal hypertension—splenomegaly is a common finding as pressure builds in the portal system. Signs of portal hypertension also include ascites and collateral vessels, and assessing the portal and hepatic veins for flow or obstruction adds important context. However, imaging alone cannot establish diagnosis or etiology; correlating these findings with clinical presentation and laboratory data (such as liver enzymes, bilirubin, INR, platelets, and serologies) is essential to confirm chronic liver disease and guide management. Options focusing on only contour, or only labs, or only portal vein thrombosis miss the broader, interconnected picture, which is why a comprehensive description that combines nodularity, contour, spleen size, portal hypertension signs, and clinical/lab correlation is the best approach.

Describing chronic liver disease on imaging relies on a complete picture of liver morphology and the downstream effects of portal hypertension, all interpreted in the clinical and laboratory context. The nodular, irregular liver surface and altered parenchymal texture point to cirrhosis, while the size of the spleen helps gauge portal hypertension—splenomegaly is a common finding as pressure builds in the portal system. Signs of portal hypertension also include ascites and collateral vessels, and assessing the portal and hepatic veins for flow or obstruction adds important context. However, imaging alone cannot establish diagnosis or etiology; correlating these findings with clinical presentation and laboratory data (such as liver enzymes, bilirubin, INR, platelets, and serologies) is essential to confirm chronic liver disease and guide management.

Options focusing on only contour, or only labs, or only portal vein thrombosis miss the broader, interconnected picture, which is why a comprehensive description that combines nodularity, contour, spleen size, portal hypertension signs, and clinical/lab correlation is the best approach.